GlassScriptPhysician profile
Kimberley D Smith
NPI 1942612890
$1,345.49
in general payments reported to CMS, 2019-2025
17 companies · $130 in 2025
The $130 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $73.78 · 2022: $210 · 2023: $700 · 2024: $232 · 2025: $130.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $871 · Travel and Lodging: $191.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $870.62 |
| Travel and Lodging | $191.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $338.48 | 2021-2025 | Intellis Adaptivestim |
| Curonix LLC | $294.50 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Collegium Pharmaceutical, INC. | $145.89 | 2022-2024 | Belbuca, Xtampza, Nucynta |
| Boston Scientific Corporation | $106.10 | 2021-2025 | Wavewriter Alpha Prime 16 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $98.39 | 2023-2025 | Xifaxan, Trulance, Relistor |
| Scilex Pharmaceuticals INC. | $83.55 | 2023 | Ztlido |
| Globus Medical, INC. | $49.13 | 2025 | Senza |
| Nevro Corp. | $42.92 | 2022-2024 | Senza |
| Azurity Pharmaceuticals, INC. | $35.39 | 2023-2024 | Horizant, Horizant |
| Redhill Biopharma INC. | $26.31 | 2021 | |
| Pfizer INC. | $22.27 | 2021 | |
| Grt US Holding, INC. | $20.46 | 2022 | |
| Averitas Pharma INC. | $19.46 | 2023 | Qutenza |
| Vertex Pharmaceuticals Incorporated | $17.50 | 2024 | |
| Horizon Therapeutics Plc | $15.48 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Forte Bio-Pharma LLC | $15.08 | 2022 | |
| Abbvie INC. | $14.58 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberley Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.